Adeno-Associated Viral Vectors in Neuroscience Research

被引:69
|
作者
Haggerty, David L. [1 ]
Grecco, Gregory G. [1 ,2 ]
Reeves, Kaitlin C. [1 ]
Atwood, Brady [1 ,3 ]
机构
[1] Indiana Univ Sch Med, Dept Pharmacol & Toxicol, 320 West 15th St,NB-400C, Indianapolis, IN 46202 USA
[2] Indiana Univ Sch Med, Med Scientist Training Program, Indianapolis, IN 46202 USA
[3] Stark Neurosci Res Inst, Indianapolis, IN 46202 USA
关键词
GENE-THERAPY VECTOR; PARKINSONS-DISEASE; VIRUS AAV; DOUBLE-BLIND; SEROTYPES; OPEN-LABEL; EFFICIENT TRANSDUCTION; ALIPOGENE TIPARVOVEC; ALZHEIMERS-DISEASE; SUBSTANTIA-NIGRA;
D O I
10.1016/j.omtm.2019.11.012
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Adeno-associated viral vectors (AAVs) are increasingly useful preclinical tools in neuroscience research studies for interrogating cellular and neurocircuit functions and mapping brain connectivity. Clinically, AAVs are showing increasing promise as viable candidates for treating multiple neurological diseases. Here, we briefly review the utility of AAVs in mapping neuro-circuits, manipulating neuronal function and gene expression, and activity labeling in preclinical research studies as well as AAV-based gene therapies for diseases of the nervous system. This review highlights the vast potential that AAVs have for transformative research and therapeutics in the neurosciences.
引用
收藏
页码:69 / 82
页数:14
相关论文
共 50 条
  • [41] Biology of adeno-associated viral vectors in the central nervous system
    Murlidharan, Giridhar
    Samulski, Richard J.
    Asokan, Aravind
    [J]. FRONTIERS IN MOLECULAR NEUROSCIENCE, 2014, 7
  • [42] Adeno-associated viral vectors for clinical gene transfer studies
    Snyder, RO
    Francis, J
    [J]. CURRENT GENE THERAPY, 2005, 5 (03) : 311 - 321
  • [43] Adeno-associated viral vectors at the frontier between tolerance and immunity
    Mingozzi, Federico
    Buening, Hildegard
    [J]. FRONTIERS IN IMMUNOLOGY, 2015, 6
  • [44] Targeting Muscle Satellite Cells with Adeno-Associated Viral Vectors
    Kwon, Jennifer
    Gersbach, Charles
    [J]. MOLECULAR THERAPY, 2018, 26 (05) : 438 - 438
  • [45] Understanding and Tackling Immune Responses to Adeno-Associated Viral Vectors
    Costa-Verdera, Helena
    Unzu, Carmen
    Valeri, Erika
    Adriouch, Sahil
    Aseguinolaza, Gloria Gonzalez
    Mingozzi, Federico
    Kajaste-Rudnitski, Anna
    [J]. HUMAN GENE THERAPY, 2023, 34 (17-18) : 836 - 852
  • [46] Novel adeno-associated viral vectors for retinal gene therapy
    Vandenberghe, L. H.
    Auricchio, A.
    [J]. GENE THERAPY, 2012, 19 (02) : 162 - 168
  • [47] Targeting phrenic motoneurons using adeno-associated viral vectors
    Argadine, Heather M.
    Clark, Leon G., Jr.
    Zhan, Wen-Zhi
    Sieck, Gary C.
    Mantilla, Carlos B.
    [J]. FASEB JOURNAL, 2011, 25
  • [48] Manufacturing of recombinant adeno-associated viral vectors for clinical trials
    Clement, Nathalie
    Grieger, Joshua C.
    [J]. MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2016, 3 : 16002
  • [49] Novel adeno-associated viral vectors for retinal gene therapy
    L H Vandenberghe
    A Auricchio
    [J]. Gene Therapy, 2012, 19 : 162 - 168
  • [50] Adipose Tissue: An Emerging Target for Adeno-associated Viral Vectors
    Bates, Rhiannon
    Huang, Wei
    Cao, Lei
    [J]. MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2020, 19 : 236 - 249